Biopharmaceutical industry confidence reached a four-year high in early 2026, according to GlobalData’s State of the Biopharmaceutical Industry 2026 Mid-Year Update, based on a survey of 157 professionals. The report shows 55% of respondents are optimistic about growth despite geopolitical
